IMX Health™ operates the first derivatives marketplace dedicated to the healthcare sector, offering tailored futures and other contracts that let insurers, pharma companies, health systems, and other participants hedge cost, volume, and performance risks. By combining anonymized claim data, big‑data analytics, and AI‑driven insights with existing market indices, the platform creates tradable, data‑backed instruments and connects risk‑averse entities with investors seeking exposure to a new healthcare‑linked asset class.
Funding
$5.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Healthcare participants face unpredictable cost and volume fluctuations in treatments, drug prices, and claim expenses, yet lack dedicated financial instruments to hedge these risks. Traditional capital market tools are not tailored to the specific dynamics of the healthcare sector, limiting risk management and investment opportunities.
Solution
IMX Health operates the first derivatives marketplace focused exclusively on healthcare, offering tailored contracts that let market participants hedge exposure to cost, volume, and performance risks. By integrating existing market indices with proprietary, data‑driven claim‑based indices, the platform creates futures and other derivative products that reflect the financial behavior of major healthcare companies and specific treatment segments. The marketplace leverages anonymized healthcare data, big‑data analytics, and AI to generate granular insights and price these contracts accurately. Participants can trade these instruments to protect against rising expenses, stabilize cash flows, or capture investment returns tied to healthcare trends. The two‑sided exchange connects risk‑averse entities with investors seeking exposure to a new asset class, fostering price discovery across the industry.
Target Audience
Primary customers include investment managers seeking new healthcare‑linked assets, insurance providers aiming to hedge expense volatility, pharmaceutical and biotech firms managing R&D and supply‑chain risks, and healthcare systems looking to offset rising treatment costs.
Features
- Equity‑based index futures that track the performance of the largest healthcare companies, enabling hedging or speculative positions.
- Proprietary claims‑based indices derived from anonymized diagnosis, treatment, claim volume, and cost data for precise risk segmentation.
- AI‑enhanced analytics platform that produces historical, seasonal, and real‑time healthcare trend insights to inform pricing and product design.
- Two‑sided marketplace architecture that matches risk‑mitigation needs of insurers, pharma, and health systems with capital from investment managers.
- Flexible contract design allowing participants to hedge specific cost drivers, supply‑chain disruptions, or procedure frequency fluctuations.